IXENSOR CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.99 TWD | -1.16% |
|
-4.77% | -28.35% |
| 05-03 | IXensor Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | IXensor Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| Sales 2021 | 24.79M 768K 1.05M | Sales 2022 | 105M 3.26M 4.46M | Capitalization | 636M 19.71M 26.94M |
|---|---|---|---|---|---|
| Net income 2021 | -73M -2.26M -3.09M | Net income 2022 | -4M -124K -169K | EV / Sales 2021 | 29.1 x |
| Net cash position 2021 | 12.86M 399K 545K | Net cash position 2022 | 30.23M 937K 1.28M | EV / Sales 2022 | 5.76 x |
| P/E ratio 2021 |
-10
x | P/E ratio 2022 |
-129
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 69.29% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.16% | ||
| 1 week | -4.77% | ||
| Current month | -0.17% | ||
| 1 month | -25.03% | ||
| 3 months | -27.83% | ||
| 6 months | -25.50% | ||
| Current year | -28.35% |
1 week
5.90
6.34
1 month
4.898.02
Current year
4.898.88
1 year
4.8912.00
3 years
4.8930.55
5 years
4.8948.00
10 years
4.8948.00
| Managers | Title | Age | Since |
|---|---|---|---|
Alan Tsai
FOU | Founder | - | 11-12-31 |
Carson Chen
FOU | Founder | - | 11-12-31 |
Chia Hsin Lin
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Peter Fitzgerald
CHM | Chairman | - | - |
Li Jen Wu
BRD | Director/Board Member | - | - |
Ya Ching Tsai
BRD | Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 5.99 | -1.16% | 38,545 |
| 24-05-02 | 6.06 | +1.00% | 28,098 |
| 24-04-30 | 6 | -1.64% | 65,383 |
| 24-04-29 | 6.1 | -3.02% | 73,833 |
| 24-04-26 | 6.29 | -0.94% | 82,893 |
End-of-day quote Taipei Exchange, May 02, 2024
More quotes
IXENSOR CO., LTD. is a Taiwan-based company mainly engaged in the development of innovative application platform for intelligent mobile devices combined with cloud computing management physiological parameters. The Company's innovative technology platform can be used to measure biochemical parameters such as luteinizing hormone, blood sugar, glycated hemoglobin, total cholesterol, high-density cholesterol, triglycerides, myocardial infarction enzymes, and other immune response parameters, such as female hormone cycle changes, infectious diseases and others. The Company's products include PixoTest Blood Glucose Monitoring System, ovulation detection system and others.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.35% | 10.18M | |
| +7.84% | 218B | |
| +7.35% | 184B | |
| +13.04% | 135B | |
| +26.03% | 107B | |
| -1.33% | 62.38B | |
| +4.81% | 50.9B | |
| +0.30% | 40.87B | |
| +2.78% | 36.28B | |
| +26.14% | 31.88B |
- Stock Market
- Equities
- 6734 Stock
